Kim Suk Bae
Department of Internal Medicine, Dankook University College of Medicine, Cheonan, South Korea.
Case Rep Gastroenterol. 2016 Oct 28;10(3):623-628. doi: 10.1159/000452208. eCollection 2016 Sep-Dec.
Hepatocellular carcinoma (HCC) is the most common type of liver cancer and its treatment options are determined by shape, liver function, loci, and stages of cancer. Diffuse type of infiltrative HCC accompanied by portal vein tumor thrombosis (PVTT) has the poorest prognosis among other HCCs and there are no other prominent treatment options than systemic chemotherapy. In this study, we report a case of a 56-year-old man with diffuse infiltrative HCC accompanied by PVTT who achieved complete remission for 8 years after receiving conventional transcatheter arterial chemoembolization using adriamycin and gelfoam.
肝细胞癌(HCC)是最常见的肝癌类型,其治疗方案由肿瘤形态、肝功能、肿瘤位置和分期决定。弥漫浸润型肝细胞癌伴门静脉癌栓(PVTT)的预后在所有肝细胞癌中最差,除全身化疗外没有其他显著的治疗选择。在本研究中,我们报告了一例56岁男性弥漫浸润型肝细胞癌伴PVTT患者,该患者在接受使用阿霉素和明胶海绵的传统经动脉化疗栓塞术后实现了8年的完全缓解。